Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Gavorestat by Applied Therapeutics for Galactosemia: Likelihood of Approval
Gavorestat is under clinical development by Applied Therapeutics and currently in Pre-Registration for Galactosemia. According to GlobalData, Pre-Registration drugs for...
Data Insights
Risk adjusted net present value: What is the current valuation of Applied Therapeutics's Gavorestat?
Gavorestat is a small molecule commercialized by Applied Therapeutics, with a leading Pre-Registration program in Galactosemia. According to Globaldata, it...